#66 Seasoned Biotech Executive Talks T-Cell Therapy And Running A Business In 2023! BioTech IQ podcast

Contenuto fornito da Ammon Rivera. Tutti i contenuti dei podcast, inclusi episodi, grafica e descrizioni dei podcast, vengono caricati e forniti direttamente da Ammon Rivera o dal partner della piattaforma podcast. Se ritieni che qualcuno stia utilizzando la tua opera protetta da copyright senza la tua autorizzazione, puoi seguire la procedura descritta qui https://it.player.fm/legal.

BioTech IQ »
#66 Seasoned Biotech Executive talks T-Cell Therapy and Running a Business in 2023!

11M ago 52:39

MP3•Pagina principale dell'episodio

Serie archiviate ("Feed non attivo" status)

When? This feed was archived on February 27, 2024 06:52 (2M ago). Last successful fetch was on October 04, 2023 21:49 (7M ago)

Why? Feed non attivo status. I nostri server non sono riusciti a recuperare un feed valido per un periodo prolungato.

What now? You might be able to find a more up-to-date version using the search function. This series will no longer be checked for updates. If you believe this to be in error, please check if the publisher's feed link below is valid and contact support to request the feed be restored or if you have any other concerns about this.

On this episode of BioTech IQ, Ammon interviews Paul Lammers the CEO of Triumvira about developing autologus cell therapies using their T-Cell Antigen Coupler Platform (TAC). During this insightful discussion Paul talks about how he started in the industry, running a biotech company in today's environment, and what sets Triumvira's T-Cell therapy apart from the rest! Don't miss it!
Show support for show https://www.buymeacoffee.com/biotechiq
Check out the books recommended by Paul:
CEO Excellence - https://amzn.to/3OGjI3G
The Emperor of All Maladies - https://amzn.to/3IDyZ1l
Support the show

Check me out on LinkedIn https://www.linkedin.com/in/ammonr/

68 episodi

#Science #MBA #Trading #Biology #Business #Ammon Rivera